Aptevo Therapeutics Inc. APVO
- APVO442 — Prostate Cancer Preclinical
- APVO452 — Prostate Cancer Preclinical
PSMA (5 companies · 7 programs)
Companies with an active program directed at PSMA.
Vir Biotechnology, Inc. VIR
- VIR-5500 — Metastatic Castration-Resistant Prostate Cancer Phase 1
- VIR-5500 — Metastatic Hormone-Sensitive Prostate Cancer Phase 1
ADC Therapeutics SA ADCT
- ADCT-241 — Prostate Cancer Preclinical
Janux Therapeutics, Inc. JANX
- JANX007 — Metastatic Castration-Resistant Prostate Cancer Phase 1
Xencor Inc XNCR
- JNJ-9401 — Metastatic Castration-Resistant Prostate Cancer Phase 1